The efficacy, safety and tolerance of calcitriol 3 μg/g ointment in the treatment of plaque psoriasis: A comparison with short-contact dithranol

Dermatology

Volumn 201, Issue 2, 2000, Pages 139-145

  Hutchinson, P E ^a   Marks, R ^b   White, J ^c  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Dithranol; Plaque psoriasis; Topical calcitriol ointment

Indexed keywords

CALCITRIOL; DITHRANOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OINTMENT; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION;

EID: 0033762738     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018457     Document Type: Article

References (31)

1. 3
2. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions
3. 3 can be safe and effective therapy of psoriasis
4. 3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes
5. 3) treatment of psoriasis: An immunohistological evaluation
6. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogues
7. The pathophysiology of psoriasis
8. 3 analogue, 1α,24-dihydroxycholecalciferol
9. 3 analogue (MC-903) in a double-blind study
10. 3) for the treatment of psoriasis
11. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study
12. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis
13. 3 metabolites and analogues in the treatment of scalp psoriasis
14. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis
15. 3) ointment in psoriasis, a safety tolerance and efficacy multicentre study
16. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: Tolerability and efficacy
17. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study
18. Comparative effects of calcipotriol solution (50 μg/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis
19. High dose topical calcipotriol consistently reduces serum parathyroid hormone levels
20. Dithranol, after 75 years still going strong
21. Skin susceptibility to dithranol: Contact allergy or irritation?
22. Intolerance and contact allergy to tar and dithranol psoriasis
23. A multi-centre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis
24. Reproducibility of clinical trials of topical glucocorticosteroids
25. Validation of sickness impact profile and psoriasis disability index in psoriasis
26. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress
27. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
28. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 migrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris
29. Psychological and psychophysiological aspects of psoriasis
30. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis
31. Evaluation of topical drug treatment in psoriasis